Industry growth is driven by demand for cost-effective generics and emerging market access Paclitaxel Injection Market Paclitaxel Injection Market Dublin, April 01, 2026 (GLOBE NEWSWIRE) -- The ...
Eli Lilly on Wednesday became the second company to gain approval for a weight-loss pill, as the multibillion-dollar market ...
April 1 () - Eli Lilly on Wednesday became the second company to gain approval for a weight-loss pill, as the ...
The weight-loss drug market is surging, with biotech firms racing to win share in a sector dominated by Novo Nordisk and Eli ...
Pfizer wants to fill a 20-year void in human Lyme disease vaccines, but must win over regulators under a vaccine-skeptical ...
The annual tick report shows Lone Star ticks have established populations along Connecticut's shoreline, raising the risk of ...
Pfizer held a close to 12% stake in ViiV Healthcare, a London-based pharmaceutical venture specialising in HIV and AIDS ...
April 1 (Reuters) - The weight-loss drug market is surging, with biotech firms racing to corner a share in a sector dominated ...
The company has not disclosed pricing or a launch timeline. The approval also comes as Novo Nordisk's Wegovy nears patent expiry later this month, potentially paving the way for lower-cost copycat ...
Colorado drugmaker Ambrosia Biosciences has landed $100 million to pursue an oral obesity drug it’s hoping can compete with a ...
Key opportunities include rising demand due to global cancer prevalence, expansion in emerging markets, and advancements in ...
Company shares climbed by more than 20% on Phase 2 study results suggesting the therapy could provide sustained relief when ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results